A. Bianco (Campobasso, Italy), W. Timens (Groningen, Netherlands)
Risk factors for asthma in morbid obese patients A. van Huisstede, J. W. Elte, A. Rudolphus, G. Mannaerts, E. Birnie, P. Hiemstra, K. Rabe, G. J. Braunstahl (Rotterdam, Netherlands)
| |
Factors associated with persistent airflow limitation in adult onset asthma M. Amelink, M. Berger, S. B de Nijs, E. J. M. Weersink, P. J. Sterk, E. H. Bel (Amsterdam, Netherlands)
| |
A decreased expression of leptin receptor may contribute to the pathogenesis of the allergic rhinitis A. Bruno, S. La Grutta, M. Ferraro, S. Gerbino, A. Bonura, P. Colombo, M. Gjomarkaj, E. Pace (Palermo, Italy)
| |
Clinical and immunological features of patients with atopy and concomitant HTLV-1 infection F. Sobrinho, A. Souza-Machado, S. Santos, G. Orge, H. Lessa, A. Cruz, E. Carvalho (Salvador, Brazil)
| |
Transcription factor GATA-3 as a specific marker of allergic bronchial asthma L. Sorokina, V. Mineev, M. Nyoma, V. Ivanov, V. Trofimov (Russian Federation)
| |
Antibody response to influenza vaccine in patients with sarcoidosis S. Tavana, Z. Sepehri, M. Keshtkar Jahromi, M. Keshtkar Jahromi, A. S. Talebian, K. Gohari Moghaddam, S. M. Razavi, S. Gholamin (Tehran, Islamic Republic Of Iran)
| |
Association between oculonasal symptoms and specific sensitization in the GEIRD project O. Bortolami, G. Verlato, M. Olivieri, S. Accordini, M. Braggion, C. Bombieri, M. Ferrari, V. Lo Cascio, L. Perbellini, E. Zanolin, R. de Marco (Verona, Italy)
| |
Asthma and allergic diseases in patients with Behçet‘s disease B. Bozkurt, H. Karamanli, R. Akgedik, M. P. Özdal, M. H. Tirhis, Z. Yildirim (Ankara, Turkey)
| |
Chronic non-asthmatic cough – Are we nearer to define the airway pathology? M. Grabowski, A. Kasran, E. Dilissen, A. Decraene, M. Litwa, L. Dupont, J. Ceuppens, D. Bullens, B. Panaszek (Wroclaw, Poland; , Belgium)
| |
Safety, PK and PD of ARRY-502, a CRTh2 antagonist, in healthy subjects with a history of seasonal allergies S. Bell, L. Anderson, C. Nugent, N. Klopfenstein, C. Eberhardt, C. Kass, L. Carter, S. Rojas-Caro, L. Burgess, B. Bergstrom, S. Miller (Boulder, United States Of America)
| |
Treatment with gp120 reduces AHR and airway inflammation in a humanized mouse model of asthma bronchiale H. Martin, S. Reuter, N. Dehzad, A. Heinz, I. Bellinghausen, S. Korn, J. Saloga, C. Becker, R. Buhl, C. Taube (Germany)
| |
Effects of intervention with high-dose inhaled corticosteroids on airway remodelling in diagnosed genetic variants of IL13 with asthma Y. Nakamura, M. Akiyama, H. Nagashima, N. Sasaki, H. Nitanai, H. Kanno, T. Sawai, T. Hirota, M. Tamari, K. Izuhara, K. Yamauchi, H. Inoue (Morioka, Yokohama, Saga, Japan)
| |
Effects of corticosteroid and montelukast treatment on distal lung parenchyma eosinophilic response in guinea pigs with chronic allergic inflammation N. Brandão Gobbato, S. B. N. Fumagalli, F. C. R. Souza, A. P. Z. Cherubim, B. D. A. Vieira, F. Gomes Reis, C. Máximo Prado, M. Arruda Martins, I. F. L. C. Tibério, E. A. Leick-Maldonado (Brazil)
| |
Fluticasone increases in vitro efferocytosis by human alveolar macrophages J. C. Todt, T. Ames, J. Sonstein, T. Polak, C. M. Freeman, M. Han, F. J. Martinez, J. L. Curtis (Ann Arbor, United States Of America)
| |
Monitoring free serum IgE in asthma patients treated with omalizumab S. Korn, I. Haasler, F. Fliedner, M. Jung, P. Strohner, A. Staatz, A. Schäfer, G. Becher, C. Taube, R. Buhl (Berlin, Bernau, Germany)
| |
The effectiveness of omalizumab in steroid-dependent asthma patients N. Yokoe, E. Yamaguti, M. Nisimura, H. Tanaka, D. Takahasi, T. Yagi, A. Kubo, K. Baba (Aichi, Japan)
| |
Follow-up of patients with moderate-severe allergic asthma treated with omalizumab D. Romero, J. I. Larco, I. Bobolea, C. Villasante, P. Barranco, S. Quirce, R. Alvarez-Sala (Madrid, Spain)
| |
Omalizumab efficacy following cat allergen exposure: Results from a randomized, double-blind, placebo-controlled, parallel-group study in patients with moderate asthma J. Corren, R. Wood, D. Patel, J. Zhu, A. Yegin, G. Dhillon, J. Fish (Los Angeles, Baltimore, South San Francisco, United States Of America; Mississauga, Canada)
| |